| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 |
| Total Revenue |
-
|
-
|
-
|
-
|
| Cost of Revenue |
-
| 170 | (85) | 85 |
|
| Gross Profit |
-
| (170) | 85 | (85) |
|
| Operating Expenses |
| Research Development | 27 | 7 | 60 | 2 |
| Selling General and Administrative | 226 | 118 | 264 | 120 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (253) | (295) | (238) | (207) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
| Earnings Before Interest And Taxes | (253) | (295) | (238) | (207) |
| Interest Expense | 7 | 0 | 2 | 2 |
| Income Before Tax | (260) | (295) | (240) | (208) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (260) | (295) | (240) | (208) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (260) | (295) | (240) | (208) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($260) | ($295) | ($240) | ($208) |
1.52% Nasdaq 0.00%
Income Statement
